Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Pharmaceutical Industry

Tag: Pharmaceutical Industry

The House provision would allow a pharmacist to make a small amount of a drug in preparation for getting a prescription from a doctor, a practice called "office use" compounding. (Sean Meyers/CVS Health via AP Images) Healthcare

Big Pharma duels with pharmacies in funding fight

Robert King · April 27, 2016 4:01 am
Rep. Lloyd Doggett (D-TX). Healthcare

House Dem: Obama not doing enough to fight drug prices

Robert King · April 26, 2016 6:06 pm
Coalition of groups wants Congress to boost funding for evaluating the value of pharmaceuticals. (AP Photo/Rafiq Maqbool, File) Healthcare

Prescription for lowering high drug prices: More money

Robert King · April 25, 2016 3:47 pm
Driving much of the increase is spending on specialty drugs that treat serious ailments. (iStock photo) Healthcare

Drug spending rises in 2015

Robert King · April 14, 2016 3:30 pm
The agency said it approved or issued a tentative approval for more than 700 drugs last year. (AP Photo/Mahesh Kumar A., File) Healthcare

FDA cleared most generic drugs ever in 2015

Robert King · April 13, 2016 6:07 pm
Valeant Pharmaceuticals CEO J. Michael Pearson is still under subpoena to appear before the committee for an April 27 hearing. (Ryan Remiorz/The Canadian Press via AP, File) Healthcare

CEO tied to high drug prices agrees to go to Senate

Robert King · April 13, 2016 2:58 pm
"Nothing has to change for current beneficiaries. I'm against anything that's bad for my mother." (AP Photo/Danny Johnston) Healthcare

Analysis doubts solution to fight high drug prices

Robert King · April 11, 2016 7:31 pm
Valeant Pharmaceuticals Inc. chief Michael Pearson skipped a deposition with the Senate Special Committee on Aging. (Ryan Remiorz/The Canadian Press via AP, File) Healthcare

Pharmaceutical CEO in Senate’s crosshairs

Robert King · April 11, 2016 4:29 pm
Rep. Elijah Cummings, D- Md., the top Democrat on the House Oversight Committee, has pushed his panel to conduct hearings about high prices. (AP Photo/Cliff Owen) Healthcare

Lawmakers limit their probes into drug prices

Robert King · April 11, 2016 4:01 am
Pfizer-Allergan merger called off in wake of Treasury rule Economy

Pfizer-Allergan merger called off in wake of Treasury rule

Joseph Lawler · April 6, 2016 11:34 am
Obama to Congress: Crack down on ‘insidious’ tax inversions Economy

Obama to Congress: Crack down on ‘insidious’ tax inversions

Joseph Lawler · April 5, 2016 4:33 pm
The price for the top-selling U.S. drug, arthritis treatment Humira, was raised 126 percent from 2011 to 2014, Reuters found. (AP Photo) Healthcare

Analysis: Prices of top drugs spike

Robert King · April 4, 2016 4:56 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 114
  • 115
  • 116
  • 117
  • 118
  • …
  • 142
  • ›Next page
Page 116 of 142
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement